Tissue Regenix Group (TRX)

 

Latest News

Issue of Equity

RNS Number: 1940A Tissue Regenix Group PLC 22 December 2017 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 22 December 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 8,307,608 ordinary shares of 0.5p each in the...

Tissue Regenix CFO resigns

Tissue Regenix Group said chief financial officer Paul Devlin has resigned. The company said it would commence a search...

Directorate Change

RNS Number: 0705Y Tissue Regenix Group PLC 01 December 2017 Tissue Regenix Group plc Directorate Change Leeds, 01 December 2017 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company, announces that the Board has accepted the resignation of Paul Devlin, CFO. The Board will commence a process to...

Issue of Equity

RNS Number: 0678Y Tissue Regenix Group PLC 01 December 2017 Tissue Regenix Group Plc Issue of equity and total voting rights Leeds, 01 December 2017 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Company"), the regenerative medical devices company,announces that it has today issued and allotted 552,337 ordinary shares of 0.5p each in the C...

All News

DateHeadlineSource
22-12-17Issue of EquityRNS
01-12-17Tissue Regenix CFO resignsStockMarketWire
01-12-17Directorate ChangeRNS
01-12-17Issue of EquityRNS
02-11-17Tissue Regenix appoints CEOStockMarketWire
02-11-17Appointment of CEORNS
18-10-17Directorate ChangeRNS
11-10-17Hardman Research: Dual revenue stream growthRNS
28-09-17Unaudited Interim ResultsRNS
18-09-17Neil Woodford's trades in August 2017Interactive Investor
08-09-17Notice of ResultsRNS
05-09-17Notification Of Major HoldingsRNS
30-08-17Issue of EquityRNS
16-08-17Holding(s) in CompanyRNS
11-08-17Holding(s) in CompanyRNS
11-08-17Holding(s) in CompanyRNS
10-08-17Holding(s) in CompanyRNS
10-08-17Holding(s) in CompanyRNS
10-08-17Hardman Research: CellRight transforming US growthRNS
10-08-17Holding(s) in CompanyRNS
09-08-17Director Deals - Tissue Regenix Group PLC (TRX)StockMarketWire
09-08-17Director Deals - Tissue Regenix Group PLC (TRX)StockMarketWire
09-08-17Director Deals - Tissue Regenix Group PLC (TRX)StockMarketWire
09-08-17Director Deals - Tissue Regenix Group PLC (TRX)StockMarketWire
09-08-17Director Deals - Tissue Regenix Group PLC (TRX)StockMarketWire
09-08-17Director Deals - Tissue Regenix Group PLC (TRX)StockMarketWire
09-08-17Director Deals - Tissue Regenix Group PLC (TRX)StockMarketWire
09-08-17Holding(s) in CompanyRNS
09-08-17Director/PDMR ShareholdingRNS
08-08-17All resolutions passed at GM of Tissue RegenixStockMarketWire
08-08-17Results of General Meeting and Total Voting RightsRNS
21-07-17Circ re.CellRight AcquisitionRNS
21-07-17Successful fundraising of ?40 millionRNS
20-07-17Proposed Acquisition and PlacingRNS
30-06-17Result of AGMRNS
02-06-17Tissue Regenix widens FY pretax loss, revenue upStockMarketWire
02-06-17Annual results for period ended 31 December 2016RNS
31-05-17Tissue Regenix updates on potential acquisition of CellRightStockMarketWire
31-05-17Potential Acquisition UpdateRNS
19-05-17Tissue Regenix looks to acquire CellRight StockMarketWire

RSS feeds

  • Editorial news feed for LSE:TRX Editorial
  • Regulatory news feed for LSE:TRX Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account